GRANEGIS 1mg tablets medication leaflet

A04AA02 granisetron • Alimentary tract and metabolism | Antiemetics and antinauseants | Serotonin (5ht3) antagonists

Granisetron is a medication used to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It belongs to a class of drugs known as 5-HT3 receptor antagonists.

This medication works by blocking the action of serotonin, a natural substance in the body that can trigger nausea and vomiting. It is available in tablet form, transdermal patches, or injectable solutions.

Granisetron is generally well-tolerated but may cause side effects such as headaches, constipation, or dizziness. In rare cases, severe allergic reactions may occur.

It is important to use granisetron as directed by your doctor and to inform medical staff about any other medications you are taking to avoid interactions.

General data about GRANEGIS 1mg

Substance: granisetron

Date of last drug list: 01-01-2019

Commercial code: W54806002

Concentration: 1mg

Pharmaceutical form: tablets

Quantity: 10

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ACTAVIS HF. - ISLANDA

Holder: EGIS PHARMACEUTICALS PLC - UNGARIA

Number: 4306/2012/02

Shelf life: 3 years

Concentrations available for granisetron

1mg, 1mg/1ml, 1mg/ml, 20mcg/ml, 2mg, 3.1mg/24h, 3mg/3ml

Other substances similar to granisetron